1
Home
Companies

Chongqing Lummy Pharmaceutical

Chongqing Lummy Pharmaceutical
Leadership team

Mr. Xue Feng Leng (Deputy GM & Vice Chairman)

Mr. Dan Cui (Deputy GM, Sec. & Gen. Counsel)

Products/ Services
Manufacturing, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Chongqing, Heilongjiang, China
Established
1999
Revenue
100M - 500M
Traded as
SZSE:300006
Social Media
URL
https://www.cqlummy.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
History

Chongqing Lummy Pharmaceutical (also known as CQL Pharma) was founded in 1999 by a team of experienced pharmaceutical executives, scientists, and entrepreneurs. Initially focused on the development and marketing of generic drugs for the Chinese market, the company quickly established itself as one of the leading manufacturers of generic drugs in China. By 2000, the company had earned a reputation for high quality products and efficient manufacturing capability. In 2002, the company began to expand its business by establishing international partnerships and expanding its marketing efforts to the global market.

Mission
Our mission is to provide quality pharmaceuticals that bring good outcomes to our customers at affordable prices.
Vision
Our vision is to become the leading pharmaceutical company in China and the world.
Key Team

Mr. Xue Feng Leng (Deputy GM & Vice Chairman)

Mr. Dan Cui (Deputy GM, Sec. & Gen. Counsel)

Recognition and Awards
CQL Pharma has won numerous awards, including being named “China’s Most Innovative Pharmaceutical Company” at the 2018 China Pharmaceutical Congress and the “Best Chinese Pharmaceutical Company Award” at the 2019 Asia Pharmaceutical Congress.
References

https://in.investing.com/equities/chongqing-lummy-pharmaceutical

https://finance.yahoo.com/quote/300006.SZ/profile?p=300006.SZ

https://www.crunchbase.com/organization/chongqing-lummy-pharmaceutical

https://www.cqlummy.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Chongqing Lummy Pharmaceutical
Leadership team

Mr. Xue Feng Leng (Deputy GM & Vice Chairman)

Mr. Dan Cui (Deputy GM, Sec. & Gen. Counsel)

Products/ Services
Manufacturing, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Chongqing, Heilongjiang, China
Established
1999
Revenue
100M - 500M
Traded as
SZSE:300006
Social Media
URL
https://www.cqlummy.com